This pattern suggests PTGER1 may be transiently upregulated during early and intermediate tumor stages, possibly reflecting a role in tumor initiation or inflammation and its potential use as a diagnostic biomarker for early-stage liver cancer, particularly stage 1 and stage 3. Here, PTGER1 is linked to neoplasm.